Literature DB >> 15905853

Childhood solid tumours: a developmental disorder.

Paul J Scotting1, David A Walker, Giorgio Perilongo.   

Abstract

Several lines of evidence demonstrate that the biology, genetics and environment of childhood solid tumours (CSTs) sets them apart from adult solid tumours. The nature of the progenitor cells from which these tumours arise, and their immature tissue environment, allows CSTs to develop with fewer defects in cell regulatory processes than adult cancers. These differences could explain why CSTs are more susceptible to therapeutic intervention than adult tumours. How does the aetiology of these cancers differ from those occurring in adults and how might this affect the development of more effective therapies?

Entities:  

Mesh:

Year:  2005        PMID: 15905853     DOI: 10.1038/nrc1633

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  47 in total

1.  Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment.

Authors:  Esterina D'Asti; Annie Huang; Marcel Kool; Brian Meehan; Jennifer A Chan; Nada Jabado; Andrey Korshunov; Stefan M Pfister; Janusz Rak
Journal:  Am J Pathol       Date:  2015-12-12       Impact factor: 4.307

Review 2.  Neonatal tumours.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2013-10-31       Impact factor: 1.827

Review 3.  Hepatoblastoma: current knowledge and promises from preclinical studies.

Authors:  Diego F Calvisi; Antonio Solinas
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

4.  Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.

Authors:  Ninib Baryawno; Afsar Rahbar; Nina Wolmer-Solberg; Chato Taher; Jenny Odeberg; Anna Darabi; Zahidul Khan; Baldur Sveinbjörnsson; O-M FuskevÅg; Lova Segerström; Magnus Nordenskjöld; Peter Siesjö; Per Kogner; John Inge Johnsen; Cecilia Söderberg-Nauclér
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

5.  PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas.

Authors:  Pramila Ramani; Aimie Norton; Michelle S Somerville; Margaret T May
Journal:  J Neurooncol       Date:  2012-03-01       Impact factor: 4.130

6.  Coopted temporal patterning governs cellular hierarchy, heterogeneity and metabolism in Drosophila neuroblast tumors.

Authors:  Raphaël Clément; Cassandra Gaultier; Sara Genovese; Florence Besse; Karine Narbonne-Reveau; Fabrice Daian; Sophie Foppolo; Nuno Miguel Luis; Cédric Maurange
Journal:  Elife       Date:  2019-09-30       Impact factor: 8.140

7.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).

Authors:  Tore Stokland; Jo-Fen Liu; James W Ironside; David W Ellison; Roger Taylor; Kathryn J Robinson; Susan V Picton; David A Walker
Journal:  Neuro Oncol       Date:  2010-09-22       Impact factor: 12.300

8.  Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.

Authors:  Suzanne Miller; Hazel A Rogers; Paul Lyon; Vikki Rand; Martyna Adamowicz-Brice; Steven C Clifford; James T Hayden; Sara Dyer; Stefan Pfister; Andrey Korshunov; Marie-Anne Brundler; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

Review 9.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

10.  DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomas.

Authors:  Géraldine Giraud; Torbjörn Ramqvist; Diana V Pastrana; Vincent Pavot; Cecilia Lindau; Per Kogner; Abiel Orrego; Christopher B Buck; Tobias Allander; Stefan Holm; Bengt Gustavsson; Tina Dalianis
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.